Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 84 Colorectal Neoplasms 42 Rectal Neoplasms 40 Carcinoma, Non-Small-Cell Lung 27 Esophageal Neoplasms 24 Esophageal Squamous Cell Carcinoma 23 Stomach Neoplasms 19 Lung Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 17 Colonic Neoplasms 17 Sarcoma 15 Pancreatic Neoplasms 15 Adenocarcinoma Of Esophagus 15 Prostatic Neoplasms 13 Neoplasm Metastasis 13 Neoplasms 12 Head and Neck Neoplasms 12 Ovarian Neoplasms 11 Carcinoma, Hepatocellular 11 Inflammatory Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Urinary Bladder Neoplasms 8 Osteosarcoma 8 Fallopian Tube Neoplasms 8 Central Nervous System Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Kidney Neoplasms 7 Multiple Myeloma 6 Glioblastoma 6 Carcinoma, Renal Cell 6

Interventions

Paclitaxel 95 Carboplatin 77 pembrolizumab 74 Cisplatin 29 Bevacizumab 27 Letrozole 22 Radiotherapy 21 Doxorubicin 21 Megestrol Acetate 20 lenvatinib 19 olaparib 18 Taxes 17 Docetaxel 17 Nivolumab 16 Specimen Handling 15 Metformin 15 dostarlimab 14 Magnetic Resonance Spectroscopy 14 Gemcitabine 13 durvalumab 12 Medroxyprogesterone Acetate 12 Trastuzumab 11 Indocyanine Green 11 Fulvestrant 11 Biopsy 11 temsirolimus 10 abemaciclib 10 atezolizumab 9 Radiation 9 Early Intervention, Educational 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Neoplasms × Neoadjuvant Therapy × Clear all

NCT05179447 2025-04-01

PROBEAT

Women's Hospital School Of Medicine Zhejiang University

Phase NA Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡